During a recent travel to Istanbul, Christian Drapeau was interviewed on Fox News Turkey after doctors using Stemregen in local hospitals reported benefits in cases of COVID-19. Some of these cases are being analyzed and prepared for publication in the scientific literature.
UPDATED:Christian Drapeau was interviewed on Fox News Turkey
About STEMREGEN®
STEMREGEN creates powerful supplements that unleash your regenerative potential by tapping into the power of your body’s innate repair system.
Disclaimer:
At STEMREGEN®, our mission is to educate on the potential of stem cells and their role in the body’s innate repair system. The information provided on this website—including articles, educational content, copy, video testimonials, and other materials—is intended solely for informational and educational purposes. Our claim is simple: STEMREGEN® supports the body’s natural repair system by increasing the number of circulating stem cells. We invite you to consider, "If you have more stem cells in circulation, what could happen?"
Our products are backed by scientific research, and we substantiate the increase in circulating stem cells through documented clinical trials and ongoing studies. We reference peer-reviewed articles and research to demonstrate the broader effects of stem cells in the body, highlighting outcomes that are grounded in science. Any research we present is based on either completed or current trials conducted by our company, ensuring that the results are credible and verifiable.
Please note that none of the content shared here is intended to make medical claims, diagnose, treat, or provide medical advice for any conditions. The personal stories and experiences shared are unique to the individuals and should not be interpreted as guarantees of specific outcomes. Always consult with a healthcare professional before beginning any new supplement or treatment. The statements on this site have not been evaluated by the FDA, and our products are not intended to diagnose, treat, cure, or prevent any disease.